Tristel plc (LON:TSTL) Insider Paul Christopher Swinney Sells 50,000 Shares

Tristel plc (LON:TSTL) insider Paul Christopher Swinney sold 50,000 shares of Tristel stock in a transaction that occurred on Tuesday, April 16th. The shares were sold at an average price of GBX 462 ($5.75), for a total transaction of £231,000 ($287,563.80).

Tristel Trading Down 1.1 %

Shares of TSTL stock opened at GBX 465 ($5.79) on Thursday. The stock has a market cap of £220.83 million, a price-to-earnings ratio of 3,576.92 and a beta of 0.28. The company has a quick ratio of 3.83, a current ratio of 4.92 and a debt-to-equity ratio of 19.12. Tristel plc has a fifty-two week low of GBX 315 ($3.92) and a fifty-two week high of GBX 503.50 ($6.27). The firm’s 50 day moving average price is GBX 460.46 and its two-hundred day moving average price is GBX 440.34.

Tristel Cuts Dividend

The firm also recently declared a dividend, which was paid on Friday, April 12th. Shareholders of record on Thursday, March 21st were given a dividend of GBX 5.24 ($0.07) per share. The ex-dividend date of this dividend was Thursday, March 21st. This represents a yield of 1.16%. Tristel’s dividend payout ratio (DPR) is 10,000.00%.

Tristel Company Profile

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers medical instrument disinfection products, including airway management, cardiology, ear, nose and throat, endoscopy, gastrointestinal physiology, laboratory, ophthalmology, phlebotomy, reproductive health/IVF, surface, ultrasound, urology, women's health, and other products under the Tristel brand.